3 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
Follow GeneCure Biotechnologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Hepatitis C Virus Vaccine HCVax - Chronic Hepatitis C Infection | Phase 1 | Unknown | GeneCure Biotechnologies | 30 | 2021-04-20 | 2021-09-29 |
| Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Covax-19™ - COVID | Phase 1 | Unknown | GeneCure Biotechnologies | 32 | 2020-07-01 | 2020-06-11 |
| Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects HIVAX, saline solution - HIV Infections | Phase 1 | Unknown | GeneCure Biotechnologies | 30 | 2010-09-01 | 2020-06-09 |
Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · HIV Infections (1)
SARS-CoV-2 recombinant spike protein with delta inulin and CpG-ODN adjuvant vaccine (1) · Saline Solution (1)
United States (2)